Immunic hosts RMS R&D Day webinar, outlines vidofludimus plans
Immunic said it is hosting a relapsing multiple sclerosis R&D Day webinar and presented vidofludimus calcium development plans in an original SEC filing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.